aTyr Pharma, Inc. announced that Srinivas Akkaraju, M.D., Ph.D., completed his term as a director of the Company and did not stand for reelection when his term as a Class III director expired at the company's 2018 Annual Meeting of Stockholders held on May 15, 2018. Dr. Akkaraju previously served as a member of the company's compensation committee and the company's strategic alliance committee. Dr. Akkaraju's decision not to stand for reelection was not a result of a disagreement with management regarding the Company's operations, policies, practices or otherwise.